Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "hyogen" return 6 results.
CEVA "STATE OF THE ART" SEMINAR & VIV ASIA 2015 BANGKOK >
Over 500 customers from all over Asia attend Ceva’s “State of the Art” seminar in Bangkok
Efficacy of Coglapix® and Hyogen® vaccines in the Prevention of Pleuropneumonia and Enzootic Pneumonia >
The aim of this study was to compare the efficacy of Coglapix® - A.p toxoid vaccine (Ceva) and Hyogen® - M. hyo vaccine (Ceva) with competitor vaccines in the farm with the history of enzootic disease...
Hyogen® with ImuvantTM - Superior Protection Against Mycoplasma hyopneumoniae infection >
- Single injection provides early and long lasting protection - Broad stimulation of the immune system with ImuvantTM - Trials demonstrate superior protection versus competitors - Expertise of the...
Ceva Lung Program - Overview >
The Ceva Lung Program (CLP) provides an overview of the diseases associated with Actinobacillus pleuropeumoniae, Mycoplasma hyopneumoniae and Aujeszky’s disease virus.
Vaccines >
Ceva is committed to swine vaccines with its Research and Development sites located in different continents worldwide investing substantial resources in innovation and production.
Swine >
Ceva is a key partner for the swine sector, thanks to a broad range of veterinary products providing the right responses to the sanitary and zoo-technical objectives of modern swine farming.